Mural Oncology (MURA)
undefined
undefined%
At close: undefined
3.64
0.69%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -207.45M -189.81M -175.43M
Depreciation & Amortization 2.57M 1.54M 1.47M
Stock-Based Compensation 24.11M 11.93M 11.50M
Other Working Capital -13.48M 7.75M 5.79M
Other Non-Cash Items - 15.01M 14.45M
Deferred Income Tax - -15.01M -14.45M
Change in Working Capital -13.48M 7.75M 5.79M
Operating Cash Flow -194.25M -168.59M -156.67M
Capital Expenditures -3.45M -5.51M -4.38M
Acquisitions - - -
Purchase of Investments - - -
Sales Maturities Of Investments - - -
Other Investing Acitivies - - -
Investing Cash Flow -3.45M -5.51M -4.38M
Debt Repayment - - -
Common Stock Repurchased - - -
Dividend Paid - - -
Other Financial Acitivies 468.81M 174.10M 161.05M
Financial Cash Flow 468.81M 174.10M 161.05M
Net Cash Flow 271.11M - -
Free Cash Flow -197.70M -174.10M -161.05M